The active ingredient in Ozempic is semaglutide in its base form
Early results from ongoing clinical studies are indicating the GLP-1 medications may successfully treat numerous other conditions including non-alcoholic fatty liver disease (known as metabolic dysfunction-associated steatohepatitis or MASH), sleep apnea, heart failure, diabetic kidney disease and Alzheimers disease
Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J
What's really going on here
WADA prohibits ibutamoren at all times under its S2 category (peptide hormones, growth factors, related substances and mimetics), so tested athletes face sanctions for any use